Back to Search
Start Over
Durability of response to VGX-3100 treatment of HPV16/18 positive cervical HSIL.
- Source :
- Human Vaccines & Immunotherapeutics; 2021, Vol. 17 Issue 5, p1288-1293, 6p
- Publication Year :
- 2021
Details
- Language :
- English
- ISSN :
- 21645515
- Volume :
- 17
- Issue :
- 5
- Database :
- Complementary Index
- Journal :
- Human Vaccines & Immunotherapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 149906826
- Full Text :
- https://doi.org/10.1080/21645515.2020.1823778